Infections (predominantly upper respiratory tract infections and urinary tract infections), blood immunoglobulin decrease (IgG, IgA, and IgM), and diarrhea are the most common treatment-emergent adverse events (8, 10). This evidence concerns the gene CD40LG and Recurrent upper respiratory tract infections.